These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 4657532)
21. [Possibilities and limits of drug supervision]. Homann G Med Klin; 1970 Aug; 65(35):1518-20. PubMed ID: 5516116 [No Abstract] [Full Text] [Related]
22. [Quality control in the pharmaceutical industry]. Sloot HA Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061 [No Abstract] [Full Text] [Related]
23. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573 [TBL] [Abstract][Full Text] [Related]
24. [Drug control in Poland]. Borkowski B Pharm Prax; 1970; 8():187-91. PubMed ID: 5524913 [No Abstract] [Full Text] [Related]
25. Veterinary drug availability. Gloyd J J Am Vet Med Assoc; 1980 Apr; 176(7):611-4. PubMed ID: 7372533 [No Abstract] [Full Text] [Related]
27. [Increasing drug utilization: viewpoint on regulation by the responsible authority]. Fischer P Soz Praventivmed; 1980 Mar; 25(1-2):5-9. PubMed ID: 7424181 [No Abstract] [Full Text] [Related]
28. [Drug industry in France: some historical points]. Sigvard J Bull Acad Natl Med; 1982 Jun; 166(6):829-34. PubMed ID: 6756598 [No Abstract] [Full Text] [Related]
29. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
30. [Factory inspection--a method of drug control]. Bill E Lakartidningen; 1968 Jun; 65():Suppl 2:97-100. PubMed ID: 5712533 [No Abstract] [Full Text] [Related]
32. Manufacturing and standardizing allergen extracts in Europe. Larsen JN; Houghton CG; Løwenstein H; Lombardero M Clin Allergy Immunol; 2004; 18():433-55. PubMed ID: 15042928 [No Abstract] [Full Text] [Related]
33. [Towards a new drug management]. Hoffmann M; Ahlner J Lakartidningen; 1995 Oct; 92(41):3804, 3807. PubMed ID: 7564634 [No Abstract] [Full Text] [Related]
34. [Drug addiction, toxicomania. Viewpoints on establishing new measures of control]. Bertschinger P Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):96-103. PubMed ID: 5141146 [No Abstract] [Full Text] [Related]
35. A lawyer's autopsy on our dead drug laws. Cullen JP Minn Med; 1973 Mar; 56(3):223-36. PubMed ID: 4734618 [No Abstract] [Full Text] [Related]
36. [Illicit traffic of narcotics and its penal repression]. Benoit J Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):86-95. PubMed ID: 5141145 [No Abstract] [Full Text] [Related]
37. The saftey evaluation of pet products. Stevenson DE Vet Rec; 1969 Feb; 84(7):168-70. PubMed ID: 5813275 [No Abstract] [Full Text] [Related]
38. [Drugs as commercial goods in the third world. Firm rules for drug sale are necessary]. Hermansson I Lakartidningen; 1996 Oct; 93(43):3788. PubMed ID: 8965552 [No Abstract] [Full Text] [Related]
39. Relative efficacy. When the government decides what drugs should be prescribed, is the patient better served? Ohio State Med J; 1972 Aug; 68(8):748-52 passim. PubMed ID: 5077306 [No Abstract] [Full Text] [Related]
40. Manufacturing misdeeds cost Abbott record-breaking payment. Lewis C FDA Consum; 2000; 34(3):38-9. PubMed ID: 11521253 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]